Binding Sites are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
Binding Sites are considered as similar when the similarity value is greater than 0.44
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3c36 | KAI | Glutamate receptor ionotropic, kainate 1 |
| PDB ID | HET | Uniprot Name | EC Number | Binding Site Similarity |
Align |
|---|---|---|---|---|---|
| 3c36 | KAI | Glutamate receptor ionotropic, kainate 1 | / | 1.000 | |
| 3c34 | KAI | Glutamate receptor ionotropic, kainate 1 | / | 0.836 | |
| 3c35 | KAI | Glutamate receptor ionotropic, kainate 1 | / | 0.653 | |
| 2pbw | DOQ | Glutamate receptor ionotropic, kainate 1 | / | 0.641 | |
| 4gxs | 0YS | Glutamate receptor 2 | / | 0.556 | |
| 1lbb | KAI | Glutamate receptor 2 | / | 0.543 | |
| 1fw0 | KAI | Glutamate receptor 2 | / | 0.525 | |
| 4h8i | 11W | Glutamate receptor ionotropic, kainate 2 | / | 0.515 | |
| 3tza | TZG | Glutamate receptor 2 | / | 0.509 | |
| 4f3g | KAI | Glutamate receptor 3 | / | 0.508 | |
| 4dld | TZG | Glutamate receptor ionotropic, kainate 1 | / | 0.501 | |
| 4bdo | KAI | Glutamate receptor ionotropic, kainate 2 | / | 0.496 | |
| 4bdr | KAI | Glutamate receptor ionotropic, kainate 2 | / | 0.496 | |
| 2wky | IBC | Glutamate receptor ionotropic, kainate 1 | / | 0.492 | |
| 1ftl | DNQ | Glutamate receptor 2 | / | 0.490 | |
| 2xxv | KAI | Glutamate receptor ionotropic, kainate 2 | / | 0.489 | |
| 1lb9 | DNQ | Glutamate receptor 2 | / | 0.480 | |
| 3k3h | BYE | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.466 | |
| 2xxy | KAI | Glutamate receptor ionotropic, kainate 2 | / | 0.463 | |
| 3v0p | 4GW | Histo-blood group ABO system transferase | / | 0.462 | |
| 2gev | COK | Pantothenate kinase | 2.7.1.33 | 0.461 | |
| 4f31 | KAI | Glutamate receptor 3 | / | 0.461 | |
| 2v59 | LZK | Biotin carboxylase | 6.3.4.14 | 0.460 | |
| 3k3e | PDB | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.460 | |
| 2y88 | 2ER | Phosphoribosyl isomerase A | 5.3.1.16 | 0.458 | |
| 3v0o | 4GW | Histo-blood group ABO system transferase | / | 0.457 | |
| 1nqu | RDL | 6,7-dimethyl-8-ribityllumazine synthase | 2.5.1.78 | 0.456 | |
| 2v58 | LZJ | Biotin carboxylase | 6.3.4.14 | 0.456 | |
| 4hbm | 0Y7 | E3 ubiquitin-protein ligase Mdm2 | 6.3.2 | 0.455 | |
| 2cwf | NDP | Delta(1)-pyrroline-2-carboxylate/Delta(1)-piperideine-2-carboxylate reductase | / | 0.453 | |
| 4wbd | ADP | Putative cysteine ligase BshC | / | 0.452 | |
| 3jsi | WTC | High affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A | / | 0.447 | |
| 3mau | EXT | Putative sphingosine-1-phosphate lyase | / | 0.447 | |
| 2ewm | NAD | (S)-1-Phenylethanol dehydrogenase | 1.1.1.311 | 0.446 | |
| 1jdz | FMB | Purine nucleoside phosphorylase | / | 0.445 | |
| 3h03 | UBP | Glutamate receptor 2 | / | 0.443 | |
| 3wv9 | FEG | Hmd co-occurring protein HcgE | / | 0.443 | |
| 2wwj | Y28 | Lysine-specific demethylase 4A | / | 0.442 | |
| 4b12 | C23 | Glycylpeptide N-tetradecanoyltransferase | / | 0.442 | |
| 5kgp | ACO | Predicted acetyltransferase | / | 0.442 | |
| 1tco | FK5 | Peptidyl-prolyl cis-trans isomerase FKBP1A | 5.2.1.8 | 0.440 | |
| 1tco | FK5 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | 3.1.3.16 | 0.440 | |
| 2b82 | ADN | Class B acid phosphatase | 3.1.3.2 | 0.440 | |
| 2jb4 | A14 | Isopenicillin N synthase | 1.21.3.1 | 0.440 | |
| 3gjw | GJW | Poly [ADP-ribose] polymerase 1 | 2.4.2.30 | 0.440 | |
| 4f7i | NAD | 3-isopropylmalate dehydrogenase | 1.1.1.85 | 0.440 | |
| 4lrr | CF9 | Thymidylate synthase | / | 0.440 | |
| 4req | 5AD | Methylmalonyl-CoA mutase large subunit | 5.4.99.2 | 0.440 |